Britta Maecker

1.2k total citations
22 papers, 875 citations indexed

About

Britta Maecker is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Britta Maecker has authored 22 papers receiving a total of 875 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 9 papers in Oncology and 5 papers in Hematology. Recurrent topics in Britta Maecker's work include Immunotherapy and Immune Responses (14 papers), T-cell and B-cell Immunology (6 papers) and Immune Cell Function and Interaction (6 papers). Britta Maecker is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), T-cell and B-cell Immunology (6 papers) and Immune Cell Function and Interaction (6 papers). Britta Maecker collaborates with scholars based in Germany, United States and Austria. Britta Maecker's co-authors include Joachim L. Schultze, Michael S. von Bergwelt‐Baildon, Lee M. Nadler, Robert H. Vonderheide, Karen S. Anderson, Marcus O. Butler, Naoto Hirano, Kai W. Wucherpfennig, Zhinan Xia and Christoph A. Klein and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Britta Maecker

22 papers receiving 866 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Britta Maecker Germany 16 525 398 204 146 116 22 875
N. Ciobanu United States 13 372 0.7× 285 0.7× 101 0.5× 98 0.7× 99 0.9× 24 672
Charles S. Hesdorffer United States 17 583 1.1× 219 0.6× 202 1.0× 86 0.6× 57 0.5× 35 837
Ken Takase Japan 14 337 0.6× 339 0.9× 146 0.7× 237 1.6× 110 0.9× 49 774
M. Brandely France 14 326 0.6× 262 0.7× 119 0.6× 164 1.1× 53 0.5× 36 760
Yasunori Nakagawa Japan 13 250 0.5× 255 0.6× 278 1.4× 232 1.6× 61 0.5× 37 688
Junjiro Tsuchiyama Japan 14 303 0.6× 271 0.7× 252 1.2× 96 0.7× 218 1.9× 30 674
DG Poplack United States 13 213 0.4× 262 0.7× 219 1.1× 138 0.9× 68 0.6× 22 716
Barbara McCoy United States 9 441 0.8× 218 0.5× 82 0.4× 190 1.3× 41 0.4× 27 636
Ugo Consoli Italy 17 239 0.5× 395 1.0× 367 1.8× 257 1.8× 102 0.9× 36 863
Sunita Badola United States 9 135 0.3× 233 0.6× 207 1.0× 152 1.0× 65 0.6× 16 729

Countries citing papers authored by Britta Maecker

Since Specialization
Citations

This map shows the geographic impact of Britta Maecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Britta Maecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Britta Maecker more than expected).

Fields of papers citing papers by Britta Maecker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Britta Maecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Britta Maecker. The network helps show where Britta Maecker may publish in the future.

Co-authorship network of co-authors of Britta Maecker

This figure shows the co-authorship network connecting the top 25 collaborators of Britta Maecker. A scholar is included among the top collaborators of Britta Maecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Britta Maecker. Britta Maecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kondo, Eisei, Britta Maecker, Andreas Draube, et al.. (2009). The shared tumor associated antigen cyclin‐A2 is recognized by high‐avidity T‐cells. International Journal of Cancer. 125(10). 2474–2478. 5 indexed citations
2.
Bohn, Georg, Matthias Hardtke‐Wolenski, Cornelia Zeidler, et al.. (2008). Lethal graft‐versus‐host disease in congenital neutropenia caused by p14 deficiency after allogeneic bone marrow transplantation from an HLA‐identical sibling. Pediatric Blood & Cancer. 51(3). 436–438. 5 indexed citations
3.
Kondo, Eisei, Britta Maecker, Martin R. Weihrauch, et al.. (2008). Cyclin D1–Specific Cytotoxic T Lymphocytes Are Present in the Repertoire of Cancer Patients: Implications for Cancer Immunotherapy. Clinical Cancer Research. 14(20). 6574–6579. 14 indexed citations
4.
Meissner, Barbara, Arndt Borkhardt, Dagmar Dilloo, et al.. (2007). Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemia. Bone Marrow Transplantation. 40(10). 945–949. 24 indexed citations
5.
Falck, Christian von, Britta Maecker, E Schirg, et al.. (2007). Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: A possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring. European Journal of Radiology. 63(3). 427–435. 47 indexed citations
6.
Klein, Christoph A., et al.. (2007). Intrathecal rituximab treatment for pediatric post‐transplant lymphoproliferative disorder of the central nervous system. Pediatric Blood & Cancer. 50(4). 886–888. 39 indexed citations
7.
Maecker, Britta & Christoph Klein. (2007). Lymphoproliferative Erkrankungen nach solider Organtransplantation. Monatsschrift Kinderheilkunde. 155(11). 1031–1039. 1 indexed citations
8.
Maecker, Britta, Dimitrios Mougiakakos, M Zimmermann, et al.. (2006). Dendritic cell deficiencies in pediatric acute lymphoblastic leukemia patients. Leukemia. 20(4). 645–649. 39 indexed citations
9.
Maecker, Britta, Michael S. von Bergwelt‐Baildon, David H. Sherr, Lee M. Nadler, & Joachim L. Schultze. (2005). Identification of a new HLA‐A*0201‐restricted cryptic epitope from CYP1B1. International Journal of Cancer. 115(2). 333–336. 19 indexed citations
10.
Maecker, Britta, Dimitrios Mougiakakos, Martin Zimmermann, et al.. (2005). Dendritic Cell Deficiencies in Pediatric Acute Lymphoblastic Leukemia Patients.. Blood. 106(11). 846–846. 1 indexed citations
11.
Maecker, Britta, Michael S. von Bergwelt‐Baildon, Karen S. Anderson, et al.. (2005). Rare naturally occurring immune responses to three epitopes from the widely expressed tumour antigens hTERT and CYP1B1 in multiple myeloma patients. Clinical & Experimental Immunology. 141(3). 558–562. 28 indexed citations
12.
Bergwelt‐Baildon, Michael von, Britta Maecker, Joachim L. Schultze, & John G. Gribben. (2004). CD40 activation: potential for specific immunotherapy in B-CLL. Annals of Oncology. 15(6). 853–857. 22 indexed citations
13.
Maecker, Britta, Karen S. Anderson, Michael S. von Bergwelt‐Baildon, et al.. (2003). Viral antigen‐specific CD8+ T‐cell responses are impaired in multiple myeloma. British Journal of Haematology. 121(6). 842–848. 37 indexed citations
14.
Hirano, Naoto, Marcus O. Butler, Michael S. von Bergwelt‐Baildon, et al.. (2003). Autoantibodies frequently detected in patients with aplastic anemia. Blood. 102(13). 4567–4575. 89 indexed citations
15.
Schmollinger, Jan C., Robert H. Vonderheide, Kara M. Hoar, et al.. (2003). Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction. Proceedings of the National Academy of Sciences. 100(6). 3398–3403. 88 indexed citations
16.
Bergwelt‐Baildon, Michael S. von, Robert H. Vonderheide, Britta Maecker, et al.. (2002). Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application. Blood. 99(9). 3319–3325. 158 indexed citations
17.
Maecker, Britta, et al.. (2001). Linking Genomics to Immunotherapy by Reverse Immunology - ‘Immunomics’ in the New Millennium. Current Molecular Medicine. 1(5). 609–619. 19 indexed citations
18.
Schultze, Joachim L., Britta Maecker, Michael S. von Bergwelt‐Baildon, Karen S. Anderson, & Robert H. Vonderheide. (2001). Tumour immunotherapy: new tools, new treatment modalities and new T‐cell antigens. Vox Sanguinis. 80(2). 81–89. 16 indexed citations
19.
Vonderheide, Robert H., Joachim L. Schultze, Karen S. Anderson, et al.. (2001). Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals.. PubMed. 61(23). 8366–70. 64 indexed citations
20.
Hirano, Naoto, Michael S. von Bergwelt‐Baildon, Britta Maecker, et al.. (2000). Distinct autoantigens in American and Japanese immune-mediated aplastic anemia.. Blood. 96(11). 6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. Ciobanu Breakdown of academic impact, for papers by Charles S. Hesdorffer Breakdown of academic impact, for papers by Ken Takase Breakdown of academic impact, for papers by M. Brandely Breakdown of academic impact, for papers by Yasunori Nakagawa Breakdown of academic impact, for papers by Junjiro Tsuchiyama Breakdown of academic impact, for papers by DG Poplack Breakdown of academic impact, for papers by Barbara McCoy Breakdown of academic impact, for papers by Ugo Consoli Breakdown of academic impact, for papers by Sunita Badola
Rankless by CCL
2026